Kidron Miriam has filed 15 insider transactions across 2 companies since January 2024.
Most recent transaction: a tax payment of 435084 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on March 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | F | Common Stock | 435084 | $3.31 | 1,133,138.0000 | 42,418,644 | 27.74% | 1.03% |
| March 25, 2026 | Lifeward Ltd. | $LFWD | Kidron Miriam | Director | A | Ordinary Shares, no par value per share | 7657 | $0.00 | 7,657.0000 | 17,732,137 | 9999.99% | 0.04% |
| March 17, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 119558 | $0.00 | 1,568,222.0000 | 42,774,504 | 8.25% | 0.28% |
| Jan. 22, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | M | Performance Stock Units | 19000 | $0.00 | 0.0000 | 42,774,504 | 100.00% | 0.04% |
| Jan. 22, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | M | Common Stock | 19000 | $0.00 | 1,448,664.0000 | 42,774,504 | 1.33% | 0.04% |
| Jan. 14, 2026 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | G | Common Stock | 86166 | $0.00 | 1,343,498.0000 | 42,774,504 | 6.03% | 0.20% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 121331 | $0.00 | 1,314,664.0000 | 42,774,504 | 10.17% | 0.28% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 115000 | $0.00 | 1,429,664.0000 | 42,774,504 | 8.75% | 0.27% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Performance Stock Units | 19000 | $0.00 | 19,000.0000 | 42,774,504 | 9999.99% | 0.04% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 52000 | $0.00 | 1,126,666.0000 | 40,828,380 | 4.84% | 0.13% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 74000 | $0.00 | 1,074,666.0000 | 40,828,380 | 7.40% | 0.18% |
| Feb. 11, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 66667 | $0.00 | 1,193,333.0000 | 40,828,380 | 5.92% | 0.16% |
| Jan. 2, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 207000 | $0.00 | 1,000,666.0000 | 40,828,380 | 26.08% | 0.51% |
| Nov. 7, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 30000 | $0.00 | 793,666.0000 | 40,896,845 | 3.93% | 0.07% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Kidron Miriam | Chief Scientific Officer | A | Common Stock | 295500 | $0.00 | 763,666.0000 | 40,566,901 | 63.12% | 0.73% |